Inhibitor of DNA Binding 3 Limits Development of Murine Slam-Associated Adaptor Protein-Dependent "Innate" γδ T cells
Creators
- 1. University of Chicago
- 2. Institute Pasteur
Description
Background: Id3 is a dominant antagonist of E protein transcription factor activity that is induced by signals emanating from the αβ and γδ T cell receptor (TCR). Mice lacking Id3 were previously shown to have subtle defects in positive and negative selection of TCRαβ+ T lymphocytes. More recently, Id3−/− mice on a C57BL/6 background were shown to have a dramatic expansion of γδ T cells.
Methodology/Principal Findings: Here we report that mice lacking Id3 have reduced thymocyte numbers but increased production of γδ T cells that express a Vγ1.1+Vδ6.3+ receptor with restricted junctional diversity. These Vγ1.1+Vδ6.3+ T cells have multiple characteristics associated with "innate" lymphocytes such as natural killer T (NKT) cells including an activated phenotype, expression of the transcription factor PLZF, and rapid production of IFNg and interleukin-4. Moreover, like other "innate" lymphocyte populations, development of Id3−/− Vγ1.1+Vδ6.3+ T cells requires the signaling adapter protein SAP.
Conclusions: Our data provide novel insight into the requirements for development of Vγ1.1+Vδ6.3+ T cells and indicate a role for Id3 in repressing the response of "innate" γδ T cells to SAP-mediated expansion or survival.
Files
journal.pone.0009303.pdf
Files
(4.4 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:75f7cf6ec4a7f9056449206f8182d170 |
2.0 MB | Preview Download |
|
md5:419050c1df4524fab239ad68faa30b81
|
2.4 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pone.0009303
- Other
- oai:uchicago.tind.io:10654
Funding
- National Institutes of Health
- R01 CA099978
- National Institutes of Health
- R01 AI073922
- National Institutes of Health
- T32 GM07281
- Leukemia and Lymphoma Society
- Scholar Award